Ignite Creation Date:
2024-05-06 @ 1:31 AM
Last Modification Date:
2024-10-26 @ 11:06 AM
Study NCT ID:
NCT01839487
Status:
COMPLETED
Last Update Posted:
2020-07-20
First Post:
2013-04-22
Brief Title:
PEGPH20 Plus Nab-Paclitaxel Plus Gemcitabine Compared With Nab-Paclitaxel Plus Gemcitabine in Participants With Stage IV Untreated Pancreatic Cancer
Sponsor:
Halozyme Therapeutics
Organization:
Halozyme Therapeutics
Key Dates - Follows AllAPIJSON File Order
Start Date:
2013-05-14
Start Date Type:
ACTUAL
Primary Completion Date:
2018-05-01
Primary Completion Date Type:
ACTUAL
Completion Date:
2018-09-26
Completion Date Type:
ACTUAL
First Submit Date:
2013-04-22
First Submit QC Date:
April 24 2013
Study First Post Date:
2013-04-25
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2020-07-20
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2019-05-07
Disp First Submit QC Date:
May 7 2019
Disp First Post Date:
2019-05-10
Disp First Post Date Type:
ACTUAL
Last Update Submit Date:
2020-07-06
Last Update Post Date:
2020-07-20
Last Update Post Date Type:
ACTUAL